![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
T Lindmark, T Nikkila and P Artursson
Department of Pharmacy, Uppsala University, Sweden.
Sodium salts of medium chain fatty acids (MCFAs) enhance the absorption of hydrophilic drugs across the intestinal mucosa, but the mechanism behind the effect is largely unknown. In this study, the dose-dependent effects of the sodium salts of four MCFAs, C6 (caproate), C8 (caprylate), C10 (caprate) and C12 (laurate), on the permeability of the hydrophilic marker molecule [14C]mannitol were studied in monolayers of the human intestinal epithelial cell line, Caco-2, grown on permeable supports. C8, C10 and C12, but not C6, enhanced the permeability of [14C]mannitol in a dose-dependent manner. Comparison of the cellular effects of the MCFAs at concentrations that gave comparable (8.1- to 8.5-fold) absorption enhancement showed that: 1) C8 was active as absorption enhancer only when the tonicity of the medium was increased; 2) absorption enhancement mediated by C10 was related to a redistribution of the cytoskeleton and structural dilatations in the tight junctions; and 3) C12 was without effect on the cytoskeleton and cellular morphology. Studies on C10 under anisotonic conditions showed that deviations from isotonicity enhanced its effect. These results suggest that structurally similar MCFAs display dramatic differences in their mechanism of action. In addition, the effects of osmolality provide an explanation for the previously reported variability in the efficacy of MCFAs as absorption enhancers.
This article has been cited by other articles:
|
|
 |
|
  J. D. Kawedia, M. Jiang, A. Kulkarni, H. E. Waechter, K. S. Matlin, G. M. Pauletti, and A. G. Menon The Protein Kinase A Pathway Contributes to Hg2+-Induced Alterations in Phosphorylation and Subcellular Distribution of Occludin Associated with Increased Tight Junction Permeability of Salivary Epithelial Cell Monolayers J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 829 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Coyne, C. M. P. Ribeiro, R. C. Boucher, and L. G. Johnson Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 440 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tavelin, V. Milovic, G. Ocklind, S. Olsson, and P. Artursson A Conditionally Immortalized Epithelial Cell Line for Studies of Intestinal Drug Transport J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1212 - 1221. [Abstract] [Full Text]
|
|
|
|
|
|
T. Lindmark, Y. Kimura, and P. Artursson Absorption Enhancement through Intracellular Regulation of Tight Junction Permeability by Medium Chain Fatty Acids in Caco-2 Cells J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 362 - 369. [Abstract] [Full Text]
|
|
|
|
|
|
P. D. P. Lundin, M. Bojrup, H. Ljusberg-Wahren, B. R. Weström, and S. Lundin Enhancing Effects of Monohexanoin and Two Other Medium-Chain Glyceride Vehicles on Intestinal Absorption of Desmopressin (dDAVP) J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 585 - 590. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
